Literature DB >> 21773974

Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function.

Nicholas W Kin1, Yao Chen, Emily K Stefanov, Richard L Gallo, John F Kearney.   

Abstract

Mammalian antimicrobial peptides (AMPs) play an important role in host defense via direct antimicrobial activity as well as immune regulation. The mouse cathelin-related antimicrobial peptide (mCRAMP), produced from the mouse gene Camp, is the only mouse cathelicidin identified and the ortholog of the human gene encoding the peptide LL-37. This study tested the hypothesis that mouse B and T cells produce and respond to mCRAMP. We show that all mature mouse B-cell subsets, including follicular (FO), marginal zone (MZ), B1a, and B1b cells, as well as CD4(+) and CD8(+) T cells produce Camp mRNA and mCRAMP protein. Camp(-/-) B cells produced equivalent levels of IgM, IgG3, and IgG2c but less IgG1 and IgE, while Camp(-/-) CD4(+) T cells cultured in Th2-inducing conditions produced more IL-4-expressing cells when compared with WT cells, effects that were reversed upon addition of mCRAMP. In vivo, Camp(-/-) mice immunized with TNP-OVA absorbed in alum produced an enhanced TNP-specific IgG1 response when compared with WT mice. ELISpot analysis revealed increased numbers of TNP-specific IgG1-secreting splenic B cells and FACS analysis revealed increased CD4(+) T-cell IL-4 expression. Our results suggest that mCRAMP differentially regulates B- and T-cell function and implicate mCRAMP in the regulation of adaptive immune responses.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21773974      PMCID: PMC3234162          DOI: 10.1002/eji.201141606

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  43 in total

1.  Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.

Authors:  Kenshi Yamasaki; Anna Di Nardo; Antonella Bardan; Masamoto Murakami; Takaaki Ohtake; Alvin Coda; Robert A Dorschner; Chrystelle Bonnart; Pascal Descargues; Alain Hovnanian; Vera B Morhenn; Richard L Gallo
Journal:  Nat Med       Date:  2007-08-05       Impact factor: 53.440

Review 2.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

3.  DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae.

Authors:  Nicholas W Kin; Dianna M Crawford; Jiabin Liu; Timothy W Behrens; John F Kearney
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

4.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Intracellular receptor for human host defense peptide LL-37 in monocytes.

Authors:  Neeloffer Mookherjee; Dustin N D Lippert; Pamela Hamill; Reza Falsafi; Anastasia Nijnik; Jason Kindrachuk; Jelena Pistolic; Jennifer Gardy; Pegah Miri; Misbah Naseer; Leonard J Foster; Robert E W Hancock
Journal:  J Immunol       Date:  2009-07-15       Impact factor: 5.422

6.  Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling.

Authors:  Fabiano Pinheiro da Silva; Richard L Gallo; Victor Nizet
Journal:  Immunol Cell Biol       Date:  2009-04-07       Impact factor: 5.126

7.  Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis.

Authors:  Yasuhide Morioka; Kenshi Yamasaki; Donald Leung; Richard L Gallo
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs.

Authors:  Anastasia Nijnik; Jelena Pistolic; Aaron Wyatt; Sheena Tam; Robert E W Hancock
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

9.  The human host defense peptide LL-37 induces apoptosis in a calpain- and apoptosis-inducing factor-dependent manner involving Bax activity.

Authors:  Jamie S Mader; Neeloffer Mookherjee; Robert E W Hancock; R Chris Bleackley
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

10.  LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells.

Authors:  Plinio Hurtado; Chen Au Peh
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

View more
  19 in total

Review 1.  Cationic host defence peptides: multifaceted role in immune modulation and inflammation.

Authors:  Ka-Yee Choi; Leola N Y Chow; Neeloffer Mookherjee
Journal:  J Innate Immun       Date:  2012-03-14       Impact factor: 7.349

2.  Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells.

Authors:  Malcolm B Lowry; Chunxiao Guo; Niels Borregaard; Adrian F Gombart
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-22       Impact factor: 4.292

Review 3.  The role of the antimicrobial peptide cathelicidin in renal diseases.

Authors:  Milan Chromek
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

4.  Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.

Authors:  Nicholas W Kin; Emily K Stefanov; Brian L P Dizon; John F Kearney
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

5.  Multiple immune-modulatory functions of cathelicidin host defense peptides.

Authors:  Ka-Yee Grace Choi; Neeloffer Mookherjee
Journal:  Front Immunol       Date:  2012-06-11       Impact factor: 7.561

6.  Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch.

Authors:  Chia-Hung Chen; Yu-Ling Lin; Yen-Ku Liu; Pei-Juin He; Ching-Min Lin; Yi-Han Chiu; Chang-Jer Wu; Tian-Lu Cheng; Shih-Jen Liu; Kuang-Wen Liao
Journal:  Int J Nanomedicine       Date:  2012-02-03

7.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

8.  Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis.

Authors:  Akhirunnesa Mily; Rokeya Sultana Rekha; S M Mostafa Kamal; Evana Akhtar; Protim Sarker; Zeaur Rahim; Gudmundur H Gudmundsson; Birgitta Agerberth; Rubhana Raqib
Journal:  BMC Pulm Med       Date:  2013-04-16       Impact factor: 3.317

9.  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.

Authors:  Karine Thivierge; Sophie Cotton; Deborah A Schaefer; Michael W Riggs; Joyce To; Maria E Lund; Mark W Robinson; John P Dalton; Sheila M Donnelly
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

10.  Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.

Authors:  Marcela Parra; Xia Liu; Steven C Derrick; Amy Yang; Jinhua Tian; Kristopher Kolibab; Sanjai Kumar; Sheldon L Morris
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.